D2L Pharma Research Solutions is a leading force in opinion leader engagement.
Established in the year 2007, D2L's ‘Discovery to Launch’ has been at the forefront of providing exemplary service to the pharmaceutical, biotechnology, and medical communications companies since its inception. We help transform market performance by forging professional partnerships between Key Opinion Leaders (KOL) and our clients.
Our KOL development strategy is designed to facilitate relationship-building that is productive for both sides.
Identification and engagement of appropriate key opinion leaders are critical to the success of a product or brand. Today, physician prescribing decisions are guided by multiple factors that are on the rise. However, key opinion leaders continue to be the consistent factor that influences physicians at the regional, national, and global levels.
D2L has come up with innovative methodologies to enable the healthcare and pharma community to connect with the opinion and thought leaders in the best KOL industry.
Services include:
No results found.
No results found.
